Secondary outcomes, as outlined in review studies: 1) improve in Visible functionality over time; 2) genotype being an effect modifier in the association between statins and development of AMD We prepared to incorporate trials that in contrast differing types of statin therapy, together with trials by which statins in combination https://jimmyd433qcm6.wikihearsay.com/user